Molecular mechanisms of interleukin-4-induced up-regulation of type I collagen gene expression in murine fibroblasts

Arthritis and Rheumatism

Volumn 48, Issue 8, 2003, Pages 2275-2284

  McGaha, Tracy L ^a,b   Le, Maithao ^b   Kodera, Takao ^b   Stoica, Cristina ^b   Zhu, Jinfang ^c   Paul, William E ^c   Bona, Constantin A ^b  

^a ROCKEFELLER UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CYTOKINE; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; LUCIFERASE; MESSENGER RNA; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SP1;

ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; ENZYME ASSAY; FIBROBLAST; FIBROSIS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SYSTEMIC SCLEROSIS; WESTERN BLOTTING;

ANIMALS; CELL LINE; COLLAGEN TYPE I; FIBROBLASTS; FIBROSIS; GENE EXPRESSION REGULATION; INTERLEUKIN-4; JANUS KINASE 1; JANUS KINASE 2; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PROMOTER REGIONS (GENETICS); PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RECEPTORS, INTERLEUKIN-4; SCLERODERMA, SYSTEMIC; STAT6 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR AP-1; UP-REGULATION;

EID: 0043074620     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11089     Document Type: Article

References (35)

1. Korn JH, LeRoy EC. The immunopathogenesis of systemic sclerosis: introduction. Int Rev Immunol 1995;12:i-v.
2. Needleman BW, Wigley FM, Stair RW. Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor a, and interferon-γ levels in sera from patients with scleroderma. Arthritis Rheum 1992;35:67-72.
3. Hasegawa M, Fujimoto M, Kikuki K, Takehara K. Elevated serum levels of interleukin-4 (IL-4), IL-10 and IL-13 in patients with systemic sclerosis. J Rheumatol 1997;24:328-32.
4. Postlethwaite AE. Role of T cells and cytokines in effecting fibrosis. Int Rev Immunol 1995;12:247-58.
5. Yamamoto T, Takagawa S, Katayama I, Yamazaki K, Hamazaki Y, Shinkai H, et al. Animal model of sclerotic skin. I. Local injections of bleomycin induce sclerotic skin mimicking scleroderma. J Invest Dermatol 1999;112:456-62.
6. Gillery P, Fertin C, Nicolas JF, Chastang F, Kalis B, Bachereau J, et al. Interleukin-4 stimulates collagen gene expression in human fibroblasts. FEBS Lett 1992;302:231-4.
7. Postlethwaite AE, Holness MA, Katai H, Raghow R. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest 1992;90:1479-85.
8. Wegrowsky Y, Paltot V, Gillery P, Kalis B, Randoux A, Marquart FX. Stimulation of sulphated glycosaminoglycan and decorin production in adult dermal fibroblasts by recombinant interleukin-4. J Biochem 1995;307:673-9.
9. Oriente A, Fedarko NS, Paccocha SE, Huang A-K, Lichtenstein LM, Essayan DM. Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts. J Pharm Exp Ther 2000;292:988-94.
10. Salmon-Ehr V, Serpier H, Nawrocki B, Gillery PH, Clavel C, Kalis B, et al. Expression of interleukin-4 in scleroderma skin specimens in fibroblast culture. Arch Dermatol 1996;132:802-6.
11. Mueller R, Krahl T, Sarvetnick N. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in NOD mice. J Exp Med 1999;184:1093-9.
12. Elbe-Burger A, Egyed A, Olt S, Klubal R, Mann U, Rappersberger K, et al. Overexpression of IL-4 alters homeostasis in the skin. J Invest Dematol 2002;118:767-78.
13. Ong C, Wong C, Roberts CR, Teh HS, Jirik FR. Anti-IL-4 treatment prevents dermal collagen deposition in the tight-skin mouse model of scleroderma. Eur J Immunol 1998;28:2619-29.
14. Ong CJ, Ip S, Teh S-J, Wong C, Jirik FR, Grusby MJ, et al. A role for helper cells in mediating skin fibrosis in tight-skin mice. Cell Immunol 1999;196:60-8.
15. Kodera T, McGaha TL, Phelps R, Paul WE, Bona CA. Disrupting the IL-4 gene rescues mice homozygous for tight-skin mutation from embryonic death and diminishes TGF-β production by fibroblasts. Proc Natl Acad Sci U S A 2002;99:3800-5.
16. McGaha T, Saito S, Phelps RG, Gordon R, Noben-Trauth N, Paul WE, et al. Lack of skin fibrosis in tight skin (TSK) mice with targeted mutation in the interleukin-4Rα and transforming growth factor-β genes. J Invest Dermatol 2001;116:136-43.
17. Keegan AD, Nelms K, Wang L-M, Pierce JH, Paul WE. Interleukin-4 receptor: signaling mechanisms. Immunol Today 1994;15:423-32.
18. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, et al. Essential role of Stat6 in IL-4 signaling. Nature 1996;380:627-30.
19. Murata T, Husain SR, Mohri H, Puri RJ. Two different IL-13 chains are expressed in normal skin fibroblasts and IL-4 and IL-13 mediate signal transduction through a common pathway. Int Immunol 1998;10:1103-10.
20. Paul WE. IL-4, a multifunctional regulator of immunity and inflammation. J Cancer Res 1991;82:1458-9.
21. Doucet C, Jasmin C, Azzarone B. Unusual interleukin-4 and 13 signaling in human normal and tumor lung fibroblasts. Oncogene 2000;19:5896-905.
22. McGaha TL, Kodera T, Spiera H, Stan AC, Pines M, Bona CA. Halofuginone inhibition of COL1A2 promoter activity via a c-Jun-dependent mechanism. Arthritis Rheum 2002;46:2748-61.
23. Bona C. Genetic defects in tight skin mice developing a scleroderma-like syndrome. Curr Dir Autoimmun 1999;1:194-207.
24. Funk WD, Pack DT, Karas RH, Wright WE, Shay JW. A transcriptionally active DNA-binding site for human p53 protein complexes. Mol Cell Biol 1992;12:2866-71.
25. Chomarat P, Bachereau J. Interleukin-4 and interleukin-13: their similarities and discrepancies. Int Rev Immunol 1998;17:1-52.
26. Hitraya EG, Varga J, Arlett CM, Jiménez SA. Identification of elements in the promoter region of α1(I) procollagen gene involved in its up-regulated expression in systemic sclerosis. Arthritis Rheum 1998;41:2048-58.
27. Vergeer WP, Sogo JM, Pretorius PJ, de Vries WN. Interaction of Ap1, Ap2, and Sp14 with the regulatory regions of the human pro-α1(I) collagen gene. Arch Biochem Biophys 2000;377:69-79.
28. Ingaki A, Truter S, Ramirez F. TGFβ stimulates α2(I) collagen production through cis-acting element that contains Sp-1 binding site. J Biol Chem 1994;269:14828-34.
29. Philips N, Bashey R, Jimenez SA. Increased α1(I) procollagen gene expression in tight skin (TSK) mice myocardial fibroblasts is due to a reduced interaction of negative regulatory sequence with AP-1. transcription factor. J Biol Chem 1995;270:9313-21.
30. Atamas SP, Luzina IG, Dai H, Wilt SG, White B. Synergy between CD40 ligation and IL-4 on fibroblast proliferation involves IL-4 receptor signaling. J Immunol 2002;168:1139-40.
31. Zang W, Ou J, Inagaki Y, Greenwel P, Ramirez F. Synergistic cooperation between Sp1 and Smad3/Smad4 mediates transforming growth factor β1 stimulation of α2(I) collagen (COL1A2) transcription. J Biol Chem 2000;275:39237-45.
32. Gingras S, Simard J, Groner B, Pfitzner E. p300/CBP is required for transcriptional induction by interleukin-4 and interacts with Stat6. Nucleic Acids Res 1999;27:2722-9.
33. Shiraski F, Makhluf HA, LeRoy EC, Watson DK, Trojanowska M. Ets transcription factors cooperate with Sp1 to activate human tenascin-C promoter. Oncogene 1999;18:7755-64.
34. Chung K-Y, Agarwal A, Uitto J, Mauviel A. An AP-1 binding sequence is essential for regulation of the human α2(I) collagen promoter activity by transforming growth factor-β. J Biol Chem 1996;272:3272-8.
35. Chen CH, Stavnezer J. Activation of the mouse Ig germline epsilon promoter by IL-4 is dependent on AP-1 transcription factors. J Immunol 2001;166:411-23.